Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 14.30 USD | -3.25% |
|
-7.74% | -8.80% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -8.8x | - | -0.03x | - | - | - | - | 1.22B | |
| 34.78x | 4.63x | 1.34x | 6.2x | 18.42x | 25.92x | 0.92% | 51.61B | |
| -21.47x | 22.73x | -0.34x | 297.59x | -22.09x | -21.08x | -.--% | 44.89B | |
| 33.46x | 6.11x | -35.05x | 3.25x | 14.02x | 21.19x | -.--% | 42.77B | |
| 49.05x | 8.3x | 0.24x | 5.7x | 31.17x | 36.01x | -.--% | 42.58B | |
| 29.21x | 2.38x | 0.6x | 8.45x | 21.35x | 25.33x | 0.39% | 31.82B | |
| 35.3x | 25.33x | 2.34x | 5.79x | 26.33x | 27.54x | -.--% | 17.33B | |
| 24.28x | 2.72x | 0.7x | 2.11x | 9.13x | 14.12x | 1.11% | 14.76B | |
| 78.97x | 4.68x | -0.35x | 4.14x | 16.07x | 19.74x | -.--% | 14.09B | |
| 29.18x | 1.38x | 0.28x | 1.92x | 11.79x | 13.42x | -.--% | 13.29B | |
| -50.96x | 26.66x | -43.54x | 8.55x | 209.18x | -2783.49x | -.--% | 13.12B | |
| 44.56x | 5.09x | 3.04x | 5.2x | 21.89x | 34.36x | 0.51% | 12.06B | |
| 60.77x | 5.19x | 0.38x | 9.32x | 26.5x | 28.95x | 0.44% | 11.34B | |
| -28.7x | 8.45x | 1.08x | 112.41x | -32x | -55.68x | -.--% | 11.12B | |
| -27.06x | 9.35x | -8.86x | 11343.53x | -22.41x | -22.07x | -.--% | 10.5B | |
| -28.9x | 9.28x | -2.76x | - | -25.52x | -25.58x | -.--% | 10.16B | |
| 33.58x | - | -0.1x | 17.57x | 32.37x | 31.59x | -.--% | 9.99B | |
| -31.1x | 8.99x | -7.11x | 81.55x | -20.73x | -20.18x | -.--% | 9.96B | |
| -16.41x | 691.6x | -0.31x | 10.76x | -17.24x | -16.64x | -.--% | 9.93B | |
| Average | 12.62x | 49.58x | -4.65x | 701.41x | 16.57x | -148.14x | 0.19% | 19.61B | |
| Weighted average by Cap. | 19.50x | 28.30x | -5.58x | 377.24x | 16.00x | -86.58x | 0.24% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
